Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Alzheimer's Disease

  Free Subscription


15.01.2018

2 Alzheimers Dement
1 BMC Neurol
1 BMJ
3 Brain
1 Brain Res
2 Curr Alzheimer Res
1 Exp Gerontol
2 JAMA
5 Neurobiol Aging
1 Proc Natl Acad Sci U S A
1 Science


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Alzheimers Dement

  1. ACOSTA D, Powell F, Zhao Y, Raj A, et al
    Regional vulnerability in Alzheimer's: The role of cell-autonomous and transneuronal processes.
    Alzheimers Dement. 2018 Jan 4. pii: S1552-5260(17)33857.
    PubMed     Text format     Abstract available

  2. LI K, O'Brien R, Lutz M, Luo S, et al
    A prognostic model of Alzheimer's disease relying on multiple longitudinal measures and time-to-event data.
    Alzheimers Dement. 2018 Jan 3. pii: S1552-5260(17)33840.
    PubMed     Text format     Abstract available


    BMC Neurol

  3. FENG L, Liao YT, He JC, Xie CL, et al
    Plasma long non-coding RNA BACE1 as a novel biomarker for diagnosis of Alzheimer disease.
    BMC Neurol. 2018;18:4.
    PubMed     Text format     Abstract available


    BMJ

  4. HAWKES N
    Pfizer abandons research into Alzheimer's and Parkinson's diseases.
    BMJ. 2018;360:k122.
    PubMed     Text format    


    Brain

  5. RICHTER N, Beckers N, Onur OA, Dietlein M, et al
    Effect of cholinergic treatment depends on cholinergic integrity in early Alzheimer's disease.
    Brain. 2018 Jan 4. pii: 4788772. doi: 10.1093.
    PubMed     Text format     Abstract available

  6. HOENIG MC, Bischof GN, Seemiller J, Hammes J, et al
    Networks of tau distribution in Alzheimer's disease.
    Brain. 2018 Jan 5. pii: 4791255. doi: 10.1093.
    PubMed     Text format     Abstract available

  7. MITO R, Raffelt D, Dhollander T, Vaughan DN, et al
    Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment.
    Brain. 2018 Jan 4. pii: 4788771. doi: 10.1093.
    PubMed     Text format     Abstract available


    Brain Res

  8. GANNON M, Wang Q
    Complex Noradrenergic Dysfunction in Alzheimer's Disease: Low Norepinephrine Input is Not Always to Blame.
    Brain Res. 2018 Jan 4. pii: S0006-8993(18)30001.
    PubMed     Text format     Abstract available


    Curr Alzheimer Res

  9. VERCRUYSSE O, Paquet C, Gabelle A, Delbeuck X, et al
    Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF biomarkers.
    Curr Alzheimer Res. 2018 Jan 9. pii: CAR-EPUB-87803.
    PubMed     Text format     Abstract available

  10. BECKER RE, Greig NH, Lahiri DK, Bledsoe J, et al
    (-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer's Disease.
    Curr Alzheimer Res. 2018 Jan 10. pii: CAR-EPUB-87805.
    PubMed     Text format     Abstract available


    Exp Gerontol

  11. HENRIQUES AD, Benedet AL, Camargos EF, Rosa-Neto P, et al
    Fluid and imaging biomarkers for Alzheimer's disease: Where we stand and where to head to.
    Exp Gerontol. 2018 Jan 4. pii: S0531-5565(17)30411.
    PubMed     Text format     Abstract available


    JAMA

  12. BENNETT DA
    Lack of Benefit With Idalopirdine for Alzheimer Disease: Another Therapeutic Failure in a Complex Disease Process.
    JAMA. 2018;319:123-125.
    PubMed     Text format    

  13. ATRI A, Frolich L, Ballard C, Tariot PN, et al
    Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials.
    JAMA. 2018;319:130-142.
    PubMed     Text format     Abstract available


    Neurobiol Aging

  14. MATHOTAARACHCHI S, Pascoal TA, Shin M, Benedet AL, et al
    Identifying incipient dementia individuals using machine learning and amyloid imaging.
    Neurobiol Aging. 2017;59:80-90.
    PubMed     Text format     Abstract available

  15. YANG S, Hilton S, Alves JN, Saksida LM, et al
    Antibody recognizing 4-sulfated chondroitin sulfate proteoglycans restores memory in tauopathy-induced neurodegeneration.
    Neurobiol Aging. 2017;59:197-209.
    PubMed     Text format     Abstract available

  16. BYUN MS, Kim HJ, Yi D, Choi HJ, et al
    Differential effects of blood insulin and HbA1c on cerebral amyloid burden and neurodegeneration in nondiabetic cognitively normal older adults.
    Neurobiol Aging. 2017;59:15-21.
    PubMed     Text format     Abstract available

  17. ARENAZA-URQUIJO EM, Bejanin A, Gonneaud J, Wirth M, et al
    Association between educational attainment and amyloid deposition across the spectrum from normal cognition to dementia: neuroimaging evidence for protection and compensation.
    Neurobiol Aging. 2017;59:72-79.
    PubMed     Text format     Abstract available

  18. SWARDFAGER W, Yu D, Scola G, Cogo-Moreira H, et al
    Peripheral lipid oxidative stress markers are related to vascular risk factors and subcortical small vessel disease.
    Neurobiol Aging. 2017;59:91-97.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  19. CONDELLO C, Lemmin T, Stohr J, Nick M, et al
    Structural heterogeneity and intersubject variability of Abeta in familial and sporadic Alzheimer's disease.
    Proc Natl Acad Sci U S A. 2018 Jan 8. pii: 1714966115.
    PubMed     Text format     Abstract available


    Science

  20. SCHWARTZ M
    Can immunotherapy treat neurodegeneration?
    Science. 2017;357:254-255.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: